Kryssen Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Investments
  • 3

  • Portfolio
  • 1

  • Exits
  • 1

Exits

Kryssen Capital General Information

Company Description

Kryssen Capital is a venture capital firm based in Wilmington, Delaware.

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 2711 Centerville Road
  • Suite 400
  • Wilmington, DE 19808
  • United States

Kryssen Capital Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Seven Bridges Genomics 01-Apr-2018 Later Stage VC Enterprise Systems (Healthcare) Generating Revenue
Axbio International 24-Oct-2017 Diagnostic Equipment Generating Revenue/Not Profitable
Seven Bridges Genomics 16-Feb-2016 Enterprise Systems (Healthcare) Generating Revenue
To view Kryssen Capital’s complete investments history, request access »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kryssen Capital Exits (1)

Company Name Exit Date Exit Type Exit Size
Seven Bridges Genomics 07-Jun-2022
To view Kryssen Capital’s complete exits history, request access »

Kryssen Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Kryssen Capital FAQs

  • What is Kryssen Capital?

    Kryssen Capital is a venture capital firm based in Wilmington, Delaware.

  • Where is Kryssen Capital headquartered?

    Kryssen Capital is headquartered in Wilmington, DE.

  • How many investments has Kryssen Capital made?

    Kryssen Capital has made 3 investments.

  • What has Kryssen Capital invested in?

    Kryssen Capital has made numerous investments in companies like Seven Bridges Genomics and Axbio International within the Enterprise Systems (Healthcare) and Diagnostic Equipment industries.

  • What has Kryssen Capital invested in recently?

    Kryssen Capital's latest investment was on 01-Apr-2018 in Seven Bridges Genomics, a company within the Enterprise Systems (Healthcare) industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process